• Latest Posts

Medigene plans to fund its T-cell program with €50 Millions

Pluristem accelerates its Cell Therapy program thanks to the EMA

[UPDATE] Adaptimmune raised €156.7M in its IPO

US-based Juno Therapeutics purchased a German biotech

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

Promethera Biosciences Raised €25,33M to Treat Liver Diseases

ADVERTISEMENT